The dominant-negative interplay between p53, p63 and p73: A family affair | Oncotarget
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53 | Journal of Ovarian Research | Full Text
Wtp53 inactivation by genetic mutations and dominant negative p53... | Download Scientific Diagram
Defining relative mutational difficulty to understand cancer formation and prevention | bioRxiv
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions: Molecular Therapy - Nucleic Acids
28.10 Tumor suppressor p53 suppresses growth or triggers apoptosis
Gene Regulation by p53 in Human Cancer System | Asian Pacific Journal of Cancer Biology
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies | Science